Hot Investor Mandate 4: Toronto-Based Global Firm Seeks to Invest Early-Stage Medical Device, Diagnostics, and Digital Health Companies

19 Apr

A firm based in Toronto that has offices worldwide manages a variety of different investment vehicles including private equity and multi-strategy funds. In the life sciences, the firm makes equity investments typically at Series A; initial investments range from $100,000-$1 million with follow on capital available of $1-3 million. The firm focuses on companies based in North America but has the capacity to invest worldwide.

In the life sciences, the firm focuses on medical devices, diagnostics and digital health companies. The firm prefers to invest in companies that are close to commercialization or which are already generating revenue (for example, device companies must ideally be ready to file for a CE Mark, 510k or Health Canada application).

The firm prefers to invest in experienced entrepreneurs who have deep knowledge of their sector. The firm only invests in companies developing products that have a clear path to market, and which serve a clear need; the firm prefers to invest in companies that are no more than a year from obtaining revenues. As the firm has offices globally, the firm is well placed to help portfolio companies make international distribution or license/royalty agreements. The firm invests in both public and privately-held companies.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: